Skip to content

A Comparison of Midazolam and Zolpidem as Oral Premedication in Children

A Comparison of Midazolam and Zolpidem as Oral Premedication in Children

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02096900
Acronym
PedsPreMed
Enrollment
86
Registered
2014-03-26
Start date
2014-07-21
Completion date
2016-05-06
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child's Anxiety, Parental/Caregiver Anxiety

Keywords

Pre-medication, Pre-operative anxiety

Brief summary

The purpose of this investigator-initiated study is to compare the efficacy of oral midazolam and zolpidem for preoperative sedation, anxiety of patient, and caregiver anxiety at the time of separation, and ease of mask acceptance at induction in children. Subjects will be randomized to receive oral medication midazolam or zolpidem approximately 30 minutes prior to surgery. No placebo will be administered in this study. Subjects will be male and female children between 2 and 9 years of age. In total, subject participation will last approximately the duration of their preoperative, perioperative, and immediate postoperative period. A member of the research team will recruit subjects preoperatively in the operating room holding area prior to surgery. Consent will take place at the time of recruitment in the preoperative holding area following a detailed explanation of the study and medications involved in the study. Participants will be of ASA (American Society of Anesthesiologists) class I-II, undergoing surgical procedures of at least 2 hours duration, and expected to remain inpatient for at least 23 hours postoperatively.

Interventions

DRUGzolpidem

Zolpidem will be given one time at 0.25 mg/kg pre-operatively

DRUGMidazolam

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric patients ages 2-9 years * ASA class I-II * inpatient surgeries of at least 2 hours duration * requiring postoperative admission of at least 23 hours

Design outcomes

Primary

MeasureTime frameDescription
Patient Anxiety at the Time of SeparationUp to 24 hours including preoperative, preoperative, and postoperative periods.The primary outcome measure of patient anxiety will be measured using the validated Modified Yale Preoperative Anxiety Score (mYPAS). The mYPAS is the current standard for evaluation of anxiety in children receiving anesthesia for surgical procedures. The modified Yale Preoperative Anxiety scale (m-YPAS) is a structured observational measure of preoperative anxiety in children. It was developed by the study group lead by Kain Z. It consists of assessment of 27 items in 5 domains of behavior indicating anxiety in young children; activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each item is weighted in calculation of the total score that ranges from 22.5 -100. Children with a score above 30 are considered anxious while those with the score of 30 or less were considered not anxious.

Secondary

MeasureTime frameDescription
Mask Acceptance ScoreDuring induction of general anesthesia.Mask acceptance by the patient, will be measured on a 4-point scale adapted from a similar trial. Score of 1 and 2 indicates satisfactory mask acceptance. Score of 3 or 4 indicates unsatisfactory mask acceptance during induction of general anesthesia.
Presence of Emergence Delirium During RecoveryUp to 30 minutes after child's first eye opening in the post-operative period.Presence or absence of emergence delirium during recovery, will be assessed using the pediatric anesthesia emergence delirium (PAED) scale recorded at 5-minute intervals for 20 minutes following the child's spontaneous eye opening. PAED score of ≥12 at any time indicates presence of emergence delirium.
Parental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)Preoperative holding area from the time of informed consent until caregiver/patient separation.Parental/caregiver anxiety, was assessed using the validated State-Trait Anxiety Inventory for Adults (STAI), a validated self-evaluation questionnaire. The STAI is compromised of separate self-report scales for measuring state and trait anxiety. The S-Anxiety scale (STAI Form Y-1) consists of twenty statements that evaluate how respondents feel right now, at this moment. The T-Anxiety scale (STAI Form Y-2) consists of twenty statements that assess how respondents generally feel. The score ranges from 20 (most relaxed) to 80 (highest stress). The baseline STAI inventory was completed by e parent/caregiver after obtaining the informed consent in the preoperative holding area and before the subject was separated from the caregiver. Baseline STAI inventory consisted of form STAIY-1 (State Anxiety) and form STAIY-2 (Trait Anxiety) anxiety. After caregiver/patient separation,form STAIY-1(State Anxiety) was completed again by the caregiver.

Countries

United States

Participant flow

Participants by arm

ArmCount
Midazolam
midazolam was given at 0.5mg/kg, pre-operatively single dose
38
Zolpidem
zolpidem was given orally 0.25mg/kg pre-operatively single dose
42
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDid not receive medication31
Overall StudySurgery cancelled- medication received11

Baseline characteristics

CharacteristicMidazolamTotalZolpidem
Age, Continuous6.34 years
STANDARD_DEVIATION 2.21
6.20 years
STANDARD_DEVIATION 2.27
6.07 years
STANDARD_DEVIATION 2.34
ASA physical status
ASA PS I
12 Participants26 Participants14 Participants
ASA physical status
AS PS II
26 Participants54 Participants28 Participants
BMI16.73 kg/m^2
STANDARD_DEVIATION 1.92
17.19 kg/m^2
STANDARD_DEVIATION 3.21
17.60 kg/m^2
STANDARD_DEVIATION 4.02
Duration of anesthesia (minutes)185.58 minutes
STANDARD_DEVIATION 72.2
196.46 minutes
STANDARD_DEVIATION 86.86
205.79 minutes
STANDARD_DEVIATION 97.6
Ethnicity (NIH/OMB)
Hispanic or Latino
22 Participants47 Participants25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants33 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Height (cm)117.32 cm
STANDARD_DEVIATION 14.55
116.29 cm
STANDARD_DEVIATION 15.23
115.34 cm
STANDARD_DEVIATION 15.92
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
36 Participants76 Participants40 Participants
Region of Enrollment
United States
38 Participants80 Participants42 Participants
Sex: Female, Male
Female
21 Participants40 Participants19 Participants
Sex: Female, Male
Male
17 Participants40 Participants23 Participants
Time from drug administration to parental separation (minutes)31.53 minutes
STANDARD_DEVIATION 12.2
33.13 minutes
STANDARD_DEVIATION 14.31
34.98 minutes
STANDARD_DEVIATION 16
Weight (kg)23.16 kg
STANDARD_DEVIATION 6.2
23.17 kg
STANDARD_DEVIATION 6.71
23.18 kg
STANDARD_DEVIATION 7.21

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 380 / 42
other
Total, other adverse events
1 / 385 / 42
serious
Total, serious adverse events
0 / 380 / 42

Outcome results

Primary

Patient Anxiety at the Time of Separation

The primary outcome measure of patient anxiety will be measured using the validated Modified Yale Preoperative Anxiety Score (mYPAS). The mYPAS is the current standard for evaluation of anxiety in children receiving anesthesia for surgical procedures. The modified Yale Preoperative Anxiety scale (m-YPAS) is a structured observational measure of preoperative anxiety in children. It was developed by the study group lead by Kain Z. It consists of assessment of 27 items in 5 domains of behavior indicating anxiety in young children; activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each item is weighted in calculation of the total score that ranges from 22.5 -100. Children with a score above 30 are considered anxious while those with the score of 30 or less were considered not anxious.

Time frame: Up to 24 hours including preoperative, preoperative, and postoperative periods.

ArmMeasureValue (MEDIAN)
MidazolamPatient Anxiety at the Time of Separation26.69 units on a scale
ZolpidemPatient Anxiety at the Time of Separation30.00 units on a scale
Secondary

Mask Acceptance Score

Mask acceptance by the patient, will be measured on a 4-point scale adapted from a similar trial. Score of 1 and 2 indicates satisfactory mask acceptance. Score of 3 or 4 indicates unsatisfactory mask acceptance during induction of general anesthesia.

Time frame: During induction of general anesthesia.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
MidazolamMask Acceptance ScoreMask acceptance score 1-234 Participants
MidazolamMask Acceptance ScoreMask acceptance score 3-44 Participants
ZolpidemMask Acceptance ScoreMask acceptance score 1-229 Participants
ZolpidemMask Acceptance ScoreMask acceptance score 3-413 Participants
Secondary

Parental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)

Parental/caregiver anxiety, was assessed using the validated State-Trait Anxiety Inventory for Adults (STAI), a validated self-evaluation questionnaire. The STAI is compromised of separate self-report scales for measuring state and trait anxiety. The S-Anxiety scale (STAI Form Y-1) consists of twenty statements that evaluate how respondents feel right now, at this moment. The T-Anxiety scale (STAI Form Y-2) consists of twenty statements that assess how respondents generally feel. The score ranges from 20 (most relaxed) to 80 (highest stress). The baseline STAI inventory was completed by e parent/caregiver after obtaining the informed consent in the preoperative holding area and before the subject was separated from the caregiver. Baseline STAI inventory consisted of form STAIY-1 (State Anxiety) and form STAIY-2 (Trait Anxiety) anxiety. After caregiver/patient separation,form STAIY-1(State Anxiety) was completed again by the caregiver.

Time frame: Preoperative holding area from the time of informed consent until caregiver/patient separation.

Population: only total of 51 subjects were analyzed. Caregivers of 29 subjects were given incorrect form to fill at time of separation rendering data not applicable for analysis for the 29 subjects.

ArmMeasureGroupValue (MEAN)Dispersion
MidazolamParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-1 (at informed consent)41.74 units on a scaleStandard Deviation 10.66
MidazolamParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-2 (at informed consent)31.81 units on a scaleStandard Deviation 8.29
MidazolamParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-1 (at separation)44.33 units on a scaleStandard Deviation 9.58
ZolpidemParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-1 (at informed consent)41.12 units on a scaleStandard Deviation 10.88
ZolpidemParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-2 (at informed consent)34.12 units on a scaleStandard Deviation 8.29
ZolpidemParental/Caregiver Anxiety Assessed Using the Validated State-Trait Anxiety Inventory for Adults (STAI)STAIY-1 (at separation)43.85 units on a scaleStandard Deviation 13.7
Secondary

Presence of Emergence Delirium During Recovery

Presence or absence of emergence delirium during recovery, will be assessed using the pediatric anesthesia emergence delirium (PAED) scale recorded at 5-minute intervals for 20 minutes following the child's spontaneous eye opening. PAED score of ≥12 at any time indicates presence of emergence delirium.

Time frame: Up to 30 minutes after child's first eye opening in the post-operative period.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
MidazolamPresence of Emergence Delirium During RecoveryNo26 Participants
MidazolamPresence of Emergence Delirium During RecoveryYes12 Participants
ZolpidemPresence of Emergence Delirium During RecoveryNo32 Participants
ZolpidemPresence of Emergence Delirium During RecoveryYes10 Participants
Post Hoc

Modified Yale Preoperative Anxiety Scale (mYPAS) Score at Separation (mYPAS2) Based on Baseline (mYPAS1) Score.

Midazolam group participants will be separated into two groups; non-anxious (mYPAS1 ≤ 30) at baseline and anxious (mYPAS1 \> 30) at baseline. The mYAPS2 scores of these two groups will be compared to the mYPAS2 scores of the Zolpidem group participants. The modified Yale Preoperative Anxiety scale (m-YPAS) is a structured observational measure of preoperative anxiety in children that takes less than a minute to preform. It consists of assessment of 27 items in 5 domains of behavior indicating anxiety in young children; activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each item is weighted in calculation of the total score that ranges from 22.5 -100. A cut off 30 on the m-YPAS scale was found to balance the high specificity and sensitivity while maintaining high positive predictive value. Children with a score above 30 are considered anxious while those with the score of 30 or less were considered not anxious.

Time frame: Up to 24 hours including pre-operative, peri-operative and post-operative periods.

ArmMeasureGroupValue (MEDIAN)
MidazolamModified Yale Preoperative Anxiety Scale (mYPAS) Score at Separation (mYPAS2) Based on Baseline (mYPAS1) Score.mYPAS2 - non-anxious baseline23.32 units on a scale
MidazolamModified Yale Preoperative Anxiety Scale (mYPAS) Score at Separation (mYPAS2) Based on Baseline (mYPAS1) Score.mYPAS2 - anxious baseline29.97 units on a scale
ZolpidemModified Yale Preoperative Anxiety Scale (mYPAS) Score at Separation (mYPAS2) Based on Baseline (mYPAS1) Score.mYPAS2 - non-anxious baseline28.30 units on a scale
ZolpidemModified Yale Preoperative Anxiety Scale (mYPAS) Score at Separation (mYPAS2) Based on Baseline (mYPAS1) Score.mYPAS2 - anxious baseline60.75 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026